FAGR Fagron SA

Disclosure of received notifications

Disclosure of received notifications

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 30 December 2019

Disclosure of received notifications

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received notifications of Norges Bank.

Notifications of Norges Bank

  • On 23 December 2019, Fagron received a notification that the shareholding of Norges Bank had crossed the disclosure threshold of 3% on 20 December 2019 as the result of the acquisition of voting securities or voting rights. A revised notification was received on 27 December 2019.
20 December 2019  
Voting rights2,243,9253.11%
Equivalent financial instruments (right to recall)50,3310.07%
Total number of voting rights2,294,2563.18%
  • On 24 December 2019, Fagron received a notification of Norges Bank that the number of (directly) held voting rights had fallen below the disclosure threshold of 3% on 23 December 2019 as the result of the disposal of voting rights.
23 December 2019  
Voting rights2,145,2312.97%
Equivalent financial instruments (right to recall)58,5100.08%
Total number of voting rights2,203,7413.05%
  • On 26 December 2019, Fagron received a notification that the shareholding of Norges Bank had fallen below the disclosure threshold of 3% (the lowest threshold) on 24 December 2019 as the result of the disposal of voting securities or voting rights.             
24 December 2019  
Voting rights2,034,0632.82%
Equivalent financial instruments (right to recall)54,9570.08%
Total number of voting rights2,089,0202.89%
  • The notifications of Norges Bank can be viewed on investors.fagron.com via this .

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information

Constantijn van Rietschoten

Chief Communications Officer

Tel. 85

Please open the link below for the press release:

EN
30/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

 PRESS RELEASE

Fagron completes acquisition of Vepakum

Fagron completes acquisition of Vepakum Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM Fagron completes acquisition of Vepakum Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was finalized following regulatory clearance from CADE in early February 2026. Vepakum operates two facilities in São Paulo, Brazil, and specializes in high-quality pharmaceutical packaging solutions. The ac...

 PRESS RELEASE

Fagron voltooit overname van Vepakum

Fagron voltooit overname van Vepakum Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 3 maart 2026 – 7:00 Fagron voltooit overname van Vepakum Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, maakt bekend dat de overname van Vepakum in Latijns-Amerika succesvol is afgerond. De transactie, die in december 2025 werd aangekondigd, kon worden voltooid nadat CADE, de Braziliaanse mededingingsautoriteit, in februari 2026 goedkeuring verleende. Vepakum beschikt over twee productiefaciliteiten in São Paulo, Brazilië, en is gespecial...

 PRESS RELEASE

Disclosure of a transparency notification from AOC Pharma S.à r.l.

Disclosure of a transparency notification from AOC Pharma S.à r.l. Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received a transparency notification from AOC Pharma S.à r.l., dated 24 February 2026. Notification from AOC Pharma S.à r.l. On 24 February 2026, Fagron received a transparency notification from AOC Pharma S.à r.l., informing the Company that its sharehold...

 PRESS RELEASE

Openbaarmaking van transparantiekennisgeving van AOC Pharma S.à r.l.

Openbaarmaking van transparantiekennisgeving van AOC Pharma S.à r.l. Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 27 februari 2026 – 18:00 CET Openbaarmaking van transparantiekennisgeving van AOC Pharma S.à r.l. Overeenkomstig de Belgische Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in beursgenoteerde vennootschappen, ontving Fagron een transparantiekennisgeving van AOC Pharma S.à r.l., gedateerd 24 februari 2026. Kennisgeving van AOC Pharma S.à r.l. Op 24 februari 2026 ontving Fagron een transparantiekennisgeving van AOC Pharma S.à r.l....

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ackermans & van Haaren: Results capping already strong subsidiary reporting. DPS beat. Fagron: Acquisition of Pharmavit Europe, active in nutraceutical raw materials. Fugro: Patience please. Kendrion: Sees signs of improvement in EU economy. Proximus: 2026 dividend halved, 2028-30 targets a bit better on lower capex. Proximus: 4Q25 in line EBITDA on weaker sales, FCF up; 2026 guidance below on EBITDA. Recticel: Strong FY25 results, CEO transition seen as a negative

ResearchPool Subscriptions

Get the most out of your insights

Get in touch